Rectal Tumors
10
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
10.0%
1 terminated out of 10 trials
87.5%
+1.0% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Study of Daily Step Count and Treatment Response in Rectal Cancer (STEP-R)
Effect of Dexmedetomidine on Lung Protection in Elderly Patients Undergoing Laparoscopic Surgery for Colorectal Cancer
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
Peptide-based Immunization for Colon- and and Pancreas-carcinoma
Reconstruction Techniques and Vascular Approach After Laparoscopic Left Hemicolectomy and Rectum Low Anterior Resection
Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy
Immunoscore in Rectal Cancer
Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial
Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer
Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before Surgery